Korean J Dermatol.
2021 Jun;59(5):321-331.
The Economic Burden of Psoriasis in Korea
- Han B1
- Jeong KH2,14
- Kim TG3,14
- Kim KJ4,14
- Kim DH5,14
- Kim BS6,14
- Park KD7
- Park CJ8,14
- Park HJ9,14
- Bang CH8,14
- Shin BS10,14
- Youn SW1,14
- Youn JI11,14
- Lee JH3,14
- Jung KE12
- Choe YB13,14
- Jo Sj1,14
- Affiliations
-
- 1Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea
- 2Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea
- 3Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea
- 4Department of Dermatology, College of Medicine, Hallym University, Anyang, Korea
- 5Department of Dermatology, CHA University School of Medicine, Seongnam, Korea
- 6Department of Dermatology, Pusan National University School of Medicine, Busan, Korea
- 7Department of Dermatology, School of Medicine, Kyungpook National University, Daegu, Korea
- 8Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 9Department of Dermatology, Inje University College of Medicine, Goyang, Korea
- 10Department of Dermatology, Chosun University Medical School, Gwangju, Korea
- 11Inshine Dermatologic Clinic, Seoul, Korea
- 12Department of Dermatology, Chungnam National University School of Medicine, Daejeon, Korea
- 13Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea
- 14The Korean Society for Psoriasis, Seoul, Korea
Abstract
- Background
Psoriasis is a chronic disease that can have accompanying comorbidities including arthritis, metabolic syndrome, and cardiovascular diseases. Patients with psoriasis tend to frequently visit medical institutions, and their economic burden for medical services is high.
Objective
To investigate the economic burden of psoriasis in Korea.
Methods
The Korean Society for Psoriasis conducted a multi-center field survey of the patients and analyzed the national insurance claim data. Also, we discussed the medical environment of psoriasis in Korea based on the results.
Results
The economic burden of psoriasis patients is substantial and varied by the type of medical institute. Patients also paid the indirect and intangible medical costs. Biological agents, which is used in patients with severe psoriasis, led to an increase in the cost.
Conclusion
This is the first study to estimate the economic burden of psoriasis in Korea comprehensively. To improve the medical environment of psoriasis and alleviate the burden of patients, discussion on the more efficient health policy and medical insurance criteria for psoriasis would be needed.